Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on March 31, 2021. The filing addresses a change in the date of the Company's 2021 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notification regarding shareholder meeting logistics and does not contain financial performance data.
Material Changes
- Annual Meeting Date Change: The 2021 Annual Meeting of Shareholders is now scheduled for June 30, 2021.
- Reason for Change: The new date is more than 30 days from the anniversary of the 2020 Annual Meeting, triggering a requirement under Rule 14a-5(f) of the Exchange Act to notify shareholders.
- Proposal Deadline: A new deadline for shareholder proposals to be included in the proxy statement has been set for April 20, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary on financial outlook, risks, contingencies, or unusual items. It strictly pertains to corporate governance procedures regarding the annual meeting.
Key Facts for Investor Verification
- Verify the final record date, time, and location of the 2021 Annual Meeting in the upcoming proxy statement.
- Note the April 20, 2021 deadline for submitting shareholder proposals for inclusion in the proxy materials.
- Confirm that no financial results or material operational changes were disclosed in this specific filing.